Frequently asked questions (FAQs)
Your frequently asked questions about REMICADE® treatment answered here:
- What is the goal of treating moderately to severely active Crohn’s disease in patients who have not responded well enough to other therapies, with REMICADE®?
- Is REMICADE® right for me?
- How is REMICADE® administered and how often do I take it?
- Has REMICADE® been widely used?
- What should I know about serious side effects?
- What should I watch out for?
- Is REMICADE® covered by insurance?
What is the goal of treating moderately to severely active Crohn’s disease in patients who have not responded well enough to other therapies, with REMICADE®?
REMICADE® goes beyond temporary relief of symptoms and provides lasting remission. Clinical studies have demonstrated that REMICADE® helps eliminate steroid use and helps heal the intestinal lining. Individual results may vary.
Is REMICADE® right for me?
Only your doctor or healthcare provider can decide if the benefits of REMICADE® are right for you.
If the decision is made to treat you with REMICADE®, you may experience control over the symptoms and flares of Crohn's disease, with as few as
6 treatments a year. That's 1 treatment every 8 weeks after the first 3 starter doses given at 0, 2, and 6 weeks. You will remain on maintenance therapy, which is just once every 8 weeks.
How is REMICADE® administered and how often do I take it?
REMICADE® is administered as a 2-hour IV infusion so that it goes right into your bloodstream to get to work. Your healthcare professional will carefully calculate and customize the right dose based on your body weight. REMICADE® is first given at 0, 2, and 6 weeks. You will remain on maintenance therapy, which is every 8 weeks. That could be as few as 6 times a year.
Has REMICADE® been widely used?
REMICADE® has been used to treat 1.8 million people worldwide with inflammatory conditions such as Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. Its safety profile has been evaluated in clinical trials conducted over the past
18 years. REMICADE® is not for everyone. Talk to your doctor to see if REMICADE® is right for you.
Why should I stay on REMICADE® therapy even if I’m feeling better?
Studies show that more patients treated on a regular 8-week schedule were able to maintain remission (periods of little or no symptoms) at 1 year—and also experienced fewer complications associated with inflammatory bowel disease (IBD). By maintaining your schedule on REMICADE®, you can maintain your remission.
What happens if I stop taking REMICADE® and then decide to go back on therapy?
When you stop taking REMICADE® and then start again, your body may react by developing antibodies against REMICADE®. This makes it difficult to start therapy again without a decrease in effectiveness.
What should I know about serious side effects?
What should I watch out for?
You should discuss any questions or concerns about your health with your doctor. Please read the Important Safety Information and the Medication Guide for REMICADE®, which includes the most common and the most serious side effects, related symptoms, and when to talk to your doctor or seek medical care. If you seek medical care from healthcare professionals other than the doctor who prescribed REMICADE®, it is important to let them know about your medical history and any current medications, including REMICADE®.
Is REMICADE® covered by insurance?
REMICADE® is covered by most insurance plans, including commercial insurers, Medicare, and Medicaid. Coverage policies may vary by insurer or even between plans offered by the same insurer. If you have any questions about insurance coverage or reimbursement, you should first call your insurance company or Medicare. If you have questions or concerns, or if you need additional information related to medical coverage or patient assistance for REMICADE®, you may call AccessOne® at 1-888-ACCESS-1 (1-888-222-3771), Monday through Friday, 8:00 AM to 8:00 PM ET.
REMICADE® can lower your ability to fight infections. Serious and sometimes fatal events can occur. There have been reports of serious infections including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that have spread throughout the body. Lymphoma, including a fatal kind called hepatosplenic T-cell lymphoma, and other cancers have been reported in children and adults taking REMICADE®. Some people with heart failure should not take REMICADE®. Other serious side effects reported include skin cancer, hepatitis B, liver injury, blood problems, allergic reactions, nervous system problems, or lupus-like syndrome. To learn more about these and other risks, please read the Important Safety Information and the Medication Guide , and talk with your doctor.